VAERS reports by lot

Merck HPV lot H021346: VAERS reports

55 VAERS reports list lot H021346 as a Merck HPV vaccine, received between 2013-05-07 and 2016-11-08. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
55
Reports
35%
Marked serious
0
With a death outcome
21
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological5633%
General / Systemic (non-local)2615%
Gastrointestinal2213%
Musculoskeletal1710%
Cardiac / Cardiovascular159%
Injection-site / Local reaction148%
Dermatological (non-injection-site)95%
Allergic / Anaphylactic42%
Autoimmune / Immune-mediated21%
Respiratory21%
Psychiatric / Neuropsychiatric21%
Reproductive / Menstrual11%

Where reports came from

U.S. state of the reporter, where given (top 12).

New York5
Michigan5
Tennessee4
New Jersey4
Ohio4
Maryland2
Texas2
Connecticut2
Colorado2
California2
Minnesota2
Alabama1

Reports by month received

2013-056
2013-067
2013-077
2013-087
2013-095
2013-103
2013-122
2014-011
2014-023
2014-031
2014-041
2014-053
2014-071
2014-081
2014-091
2014-121
2015-021
2015-091
2015-101
2015-111
2016-111

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.